ABSTRACT: An original method has been developed for the synthesis of 1,3-dyine derivatives of natural lembehyne B in high yields (50−67%) and with high selectivity (>98%). The key stage of the synthesis is new Ti-catalyzed cross-cyclomagnesiation of oxygenated and aliphatic 1,2-dienes induced by Grignard reagents. For studying the effect of the structure on the antitumor and neuritogenic activities, a series of lembehyne B analogues with different distances between the terminal hydroxy group and the 1,3-diyne moiety was prepared and tested for neuritogenic activity on mouse neuroblastoma Neuro 2A cells and for cytotoxicity, induction of apoptosis, and effects on the cell cycle using Jurkat, U937, K562, HeLa, and Hek293 tumor cell lines.
INTRODUCTION
Higher acetylenic alcohols and their derivatives are encountered in many plants, algae, marine invertebrates, and higher fungus species, 1−8 and more than 1000 acetylenic compounds have been isolated and identified to date. For many years, increasing interest has been shown in these organic compounds, largely owing to the important biological activities they exhibit, in particular, antitumor, antimicrobial, antiparasitic, antibacterial, antifungal, and other types of activities. 4−16 Among the diverse alkynol derivatives known to date, derivatives of carbinols containing one or several triple bonds in the α-position to the hydroxy group are the most abundant. 1−5 In addition, it has been shown by Japanese researchers that higher alkynols, lembehynes A−C, containing bis-methyleneseparated Z-double bonds in the molecules, isolated in nanoconcentrations from Indonesian sea sponges Haliclona sp., show a high neuritogenic activity against mouse neuroblastoma Neuro 2A cells and rat pheochromocytoma PC12 cells. 17−20 Therefore, these compounds can be considered as the base for the development of modern drugs for the treatment of neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, Huntington's chorea and so on).
Meanwhile, studies along this line were considerably held up by the exceptionally low content of lembehynes in sea sponges and the lack of efficient methods for their total synthesis. Therefore, we developed original stereoselective approaches both for the preparation of key monomers and for the total synthesis of lembehynes A and B 21−24 using the Ti-catalyzed cross-cyclomagnesiation of oxygenated and aliphatic 1,2-dienes on treatment with Grignard reagents, which we discovered. 25−27 In addition, it was shown for the first time by flow cytometry that lembehyne B can induce early apoptosis in various types of leukemia cells. 22 As a continuation of the studies dealing with stereoselective synthetic routes to lembehyne derivatives and the influence of their structure on the antitumor and neuritogenic activities, here, we report a stereoselective method for the synthesis of lembehyne B 1,3-diyne derivatives, close structural analogues of natural strongylodiols, 28−30 pellynols, 31 and halicynones, 32 which exhibit a broad range of biological activities. In addition, we planned to pay particular attention to testing of the antitumor and neuritogenic activities of the compounds by means of modern flow cytometry and phase-contrast microscopy.
RESULTS AND DISCUSSION
2.1. Chemistry. According to the previously developed scheme for the preparation of racemic lembehyne B, 21 we first prepared (13Z,17Z)-tetraconta-13,17-dienal (4) in a 79% yield by cross-cyclomagnesiation of 1,2-nonadediene (1) and 2-tetradeca-12,13-dien-1-yl-1,3-dioxolane (2) on treatment with EtMgBr in the presence of Mg metal and a catalytic amount of Cp 2 TiCl 2 (10 mol %) (1/2/EtMgBr/Mg/[Ti] = 12:10:30:20:0.1, Et 2 O, 20−22°C, 7 h) (Scheme 1). This was followed by a successive reaction of aldehyde 4 with presynthesized 1-lithium-4-trimethylsilyl-1,3-butadiyne and removal of the trimethylsilyl group on treatment with trimethylbutylammonium fluoride (TBAF) in tetrahydrofuran (THF) to give the target 1,3-diyne rac-lembehyne B analogue 6 in ∼66% yield (Scheme 1).
Subsequently, we developed a synthetic route to 1,3-diyne derivatives of natural lembehyne B with the R-configuration of the hydroxy group by the direct addition of 1-bromoalkynes to lembehyne B 22 synthesized from aldehyde 4 according to Scheme 2:
First, racemic 8 and natural lembehyne B (10) were synthesized according to a previously developed scheme 21−24 by the successive addition of lithium trimethylsilylacetylenide to aldehyde 4, deprotection of the resulting alkyne 7, oxidation of alcohol 8, and stereoselective reduction of ketone 9 at the final step. The reactions of natural lembehyne B (10) with 1-bromo-2-trimethylsilylacetylene or 1-bromo-2-(ω-hydroxyalkyl)acetylenes in the presence of CuCl afforded the target 1,3-diyne lembehyne B derivatives 11 and 12a−d in high yields.
In the second stage, we initiated a study of antitumor and neuritogenic activities of the synthesized 1,3-diynes in comparison with those of the initial lembehyne B.
2.2. Biology. The cytotoxicity of lymbehynes B and their derivatives (altogether six compounds) was evaluated using a We tested two 1,3-diyne derivatives 6 and 11 based on the racemic and natural lembehyne B and four ω-hydroxy-1,3-diyne lembehyne B (10) derivatives (12a−d) with different distances between the hydroxy group and the 1,3-diyne moiety. Cytotoxicity assays of these compounds against Jurkat, K562, U937, and HeLa tumor cells and Hek293 embryonic cells showed that 1,3-diyne 6 based on racemic lembehyne B has a somewhat lower cytotoxic activity against these cell lines than its analogue 11 synthesized using natural lembehyne B. The highest cytotoxicity was found for compound 12c, the cytotoxicity of which was higher for suspension cultures (Jurkat, K562, U937) than for adhesion cultures ( Table 1) .
The lembehyne B derivatives at a concentration of 0.60 μM/mL induced apoptosis of 87% of Jurkat tumor cells ( Figure 1A ), 15% being early apoptosis (Q7-4) and more than 71% being late apoptosis (Q7-2).
Thus, lembehyne B derivatives show a dose-dependent influence on the cell population and induce early and late apoptosis; meanwhile, the initial lembehyne B has been previously shown to induce, most of all, early apoptosis. Figure 2 shows the results of the study of the cell cycle phases for Jurkat cells carried out by flow cytometry within 24 h after the cells were treated with compound 12c at various concentrations.
The Jurkat, K562, U937, HeLa, and Hek293 cell cycle characteristics in the control samples showed a considerable predominance of cells in the G0−G1 phase and a balance between the synthesis (S phase) and apoptosis (sub-G0−G1) processes.
Within 24 h after exposure to compound 12c, virtually in all tumor cell lines, most of all in the suspension Jurkat, The maximum number of cells with neurites, whose length exceeds the body length of the neuron, observed in the concentration range 0.2 nM, incubation 72 h, in %. 
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http://pubs.acs.org/journal/acsodf Article K562, and U937 cells, apoptosis processes predominated (increased sub-G0−G1 stage), with retained or even somewhat enhanced ability of cells to DNA synthesis (S phase). This was accompanied by a decreasing fraction of cells in the G0−G1 phase, together with an increasing proliferation block and a decreasing proliferation index due to a decrease in the number of cells in the G2 + M phase ( Figure 2A ). All of the foregoing may be indicative of the cytotoxic activity of compound 12c against chronic myeloid, T-cell leukemia, and histiocytic lymphoma cells caused by the ability of these compounds to induce apoptosis.
A comparison of the data on the effects of natural lembehyne B and its 1,3-diyne analogue 12c on the cell cycle showed some differences. Whereas lembehyne B mainly arrests the cell cycle in the G1 phase, apart from the accumulation of hypodiploid cells (G0), the 1,3-diyne analogues directly affect the S phase by stopping it and decreasing the G2 cell population, which also finally contributes to the hypodiploid cell population.
Like other derivatives that we studied, compound 12c stimulated the growth of neurites in the Neuro 2A cell culture; however, unlike other compounds, 12c showed a very high differentiating activity toward neuroblastoma cells, which was manifested even at low concentrations ( Figure 3 and Table 1 ). When the time of cell incubation with 1,3-diyne 12c increased, the differentiation was enhanced and neurite branching and elongation took place (Figure 3 ). The advantage of the neurite branching and length for the cells incubated in the medium with compound 12c can be clearly seen in Figure 3 . In other words, compound 12c may prove to be not inferior in activity to neuro growth factor (NGF); however, for a better understanding of the cellular processes induced by lembehyne derivatives, further research into the molecular transformations involved in the lembehyne-induced neuritogenesis is required.
A completely different cell cycle situation is found by flow cytometry for the treatment of Neuro 2A cells with the show, first, somewhat enhanced capability of cells for DNA synthesis (increased S phase) and then, by the end of the third day, a clearly defined decrease in the S and G2 phases, i.e., almost complete cell disappearance during mitosis. The obtained data suggest that under the action of lembehyne B, the mouse neuroblastoma cells are likely to undergo differentiation, which is confirmed by the activation of neuritogenesis.
CONCLUSIONS
Thus, as a continuation of our research on the development of original methods for the stereoselective synthesis of natural alkynols containing bis-methylene-separated Z-double bonds, we synthesized a series of 1,3-diyne analogues of natural lembehyne in high yields and with high selectivity. Biological activity assays in vitro revealed the high potential of these compounds as bases for the development of modern antitumor or neuritogenic agents for the treatment of socially significant human diseases. Currently, we are carrying out intensive research in this area dealing with the investigation of the molecular mechanisms of lembehyne-induced neuritogenesis and the antitumor activity of natural and synthetic lembehynes using advanced molecular biological approaches of flow cytometry, multiparameter analysis of signaling pathways, immunohistochemical studies, Western blotting, and fluorescence spectroscopy.
EXPERIMENTAL SECTION
4.1. Materials and Methods. All solvents were dried (1,4-dioxane, tetrahydrofuran, diethyl ether over Na) and freshly distilled before use. All reactions were carried out under a dry argon atmosphere.
1 H and 13 C NMR spectra were obtained using a Bruker AVANCE 400 spectrometer in CDCl 3 operating at 400 MHz for 1 H and 100 MHz for 13 C. High-resolution mass spectra (HRMS) were measured on an instrument using a time-of-flight (TOF) mass analyzer with electrospray ionization (ESI). Elemental analyses were performed on an 1106 Carlo Erba apparatus. The individuality and purity of the synthesized compounds were controlled using thin-layer chromatography (TLC) on Sorbfil plates; anisic aldehyde in acetic acid was used as a developer. Column chromatography was carried out on an Acrus silica gel (0.060−0.200 mm). Aliphatic and oxygenated 1,2-dienes and lembehyne B have been synthesized according to previously developed procedures. 
Procedure for the Preparation of 1,3-Diyne (5).
To a solution of 4-trimethylsilyl-1,3-butadiyne 0.73 g (6 mmol) in THF (10 mL), a solution of 4 mL n-BuLi (1.5 M in hexane) was added dropwise at −40°C. The solution was stirred for 1 h at −40 to 0°C and then added dropwise to THF solution of 1.5 g (3.08 mmol) dienal (4) at −10°C. The reaction mixture was warmed up to ambient temperature and stirred for 3 days. The reaction mixture was treated with a 5% solution of NH 4 Cl in H 2 O (20 mL) and extracted with diethyl ether (2 × 100 mL). The combined organic phases were dried over MgSO 4 , filtered, and the solvents were removed under vacuum. Silica gel column chromatography of the residue gave compound 5 (1.59 g, 85%) as a pale yellow oily liquid. (5) 1.17 g (2 mmol) in THF (10 mL), TBAF (1 M in THF, 1.2 equiv) was added at 0°C, the solution was stirred for 4 h at ambient temperature and then added dropwise to a THF solution of 1.5 g (3.08 mmol) dienal (6) at −10°C. The reaction mixture was treated with saturated aq. NaCl and extracted with diethyl ether (2 × 50 mL). The combined organic phases were dried over MgSO 4 , filtered, and the solvents were removed under vacuum. Silica gel column chromatography of the residue gave compound 6 (1.07 g, 99%) as a colorless waxy solid. and cultured according to standard protocols and a sterile technique. The cell lines were shown to be free from viral contamination and mycoplasma. HeLa and Hek293 cell lines were cultured as monolayers and maintained in Dulbecco's modified Eagle's medium (DMEM, Gibco BRL) supplemented with 10% fetal bovine serum (FBS) and a 1% penicillin−streptomycin solution at 37°C in a humidified incubator under a 5% CO 2 atmosphere. Cells were maintained in RPMI 1640 (Jurkat, K562, U937) (Gibco) supplemented with 4 μM glutamine, 10% FBS (Sigma), and 100 units/mL penicillin−streptomycin (Sigma). All types of cells were grown in an atmosphere of 5% CO 2 at 37°C. The cells were subcultured at 2−3 days intervals. Adherent cells (HeLa) were suspended using trypsin/ethylenediaminetetraacetic acid (EDTA) and counted after they had reached 80% confluency. Cells were then seeded in 24-well plates at 5 × 
(17Z,21Z)-1-(Trimethylsilyl)octatriaconta-17,21-dien-1,3-diyn-5-ol (5).

